Lan Chou-Chin, Lee Chung, Jao Lun-Yu, Wu Yao-Kuang, Huang Kuo-Liang, Su Wen-Lin, Huang Yi-Chih, Wu Chih-Wei, Yang Mei-Chen
Division of Pulmonary Medicine, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei City 23142, Taiwan.
School of Medicine, Tzu Chi University, Hualien 97004, Taiwan.
Biomedicines. 2025 Apr 8;13(4):905. doi: 10.3390/biomedicines13040905.
This review aims to explore the epidemiology, pathophysiology, risk factors, and diagnostic approaches of obstructive sleep apnea syndrome and small airway disease, emphasizing their interrelationship and implications for clinical management. A comprehensive analysis of the literature was conducted to examine shared and distinct characteristics of obstructive sleep apnea syndrome and small airway disease. Risk factors, clinical presentations, diagnostic tools, and management strategies were reviewed to identify potential areas for improvement in care. Obstructive sleep apnea syndrome, characterized by intermittent upper airway obstruction during sleep, contributes to fragmented sleep and systemic diseases. Small airway disease involves inflammation and obstruction of the small airways, impairing airflow and gas exchange. Shared risk factors, such as obesity, smoking, and age, were identified as contributors to the development and progression of both conditions. The co-occurrence of obstructive sleep apnea syndrome and small airway disease exacerbates respiratory symptoms and increases the risk of comorbidities, such as pulmonary hypertension, heart failure, and respiratory failure. Recognition of their interplay highlights the need for integrated diagnostic and therapeutic strategies. The interrelationship between obstructive sleep apnea syndrome and small airway disease underscores the importance of integrated management approaches to improve patient outcomes. Addressing shared risk factors and understanding the interplay between these conditions are crucial for optimizing care. This review identifies key knowledge gaps, including the need for precise diagnostic tools and targeted therapies, which are essential for advancing personalized treatment strategies for individuals with obstructive sleep apnea syndrome and small airway disease.
本综述旨在探讨阻塞性睡眠呼吸暂停综合征和小气道疾病的流行病学、病理生理学、危险因素及诊断方法,重点阐述它们的相互关系以及对临床管理的意义。对文献进行了全面分析,以研究阻塞性睡眠呼吸暂停综合征和小气道疾病的共同特征和不同特征。对危险因素、临床表现、诊断工具及管理策略进行了综述,以确定护理中潜在的改进领域。阻塞性睡眠呼吸暂停综合征的特征是睡眠期间间歇性上气道阻塞,可导致睡眠碎片化和全身性疾病。小气道疾病涉及小气道的炎症和阻塞,会损害气流和气体交换。肥胖、吸烟和年龄等共同危险因素被确定为这两种疾病发生和进展的促成因素。阻塞性睡眠呼吸暂停综合征和小气道疾病同时存在会加重呼吸道症状,并增加诸如肺动脉高压、心力衰竭和呼吸衰竭等合并症的风险。认识到它们之间的相互作用凸显了综合诊断和治疗策略的必要性。阻塞性睡眠呼吸暂停综合征和小气道疾病之间的相互关系强调了综合管理方法对改善患者预后的重要性。解决共同的危险因素并了解这些疾病之间的相互作用对于优化护理至关重要。本综述确定了关键的知识空白,包括需要精确的诊断工具和靶向治疗,这对于推进阻塞性睡眠呼吸暂停综合征和小气道疾病患者的个性化治疗策略至关重要。